Crotoxin suppresses the tumorigenic properties and enhances the antitumor activity of Iressa® (gefinitib) in human lung adenocarcinoma SPCA-1 cells

Molecular Medicine Reports

Volumn 10, Issue 6, 2014, Pages 3009-3014

  Wang, Junhua ^a   Qin, Xiuguang ^a   Zhang, Zhiqiang ^a   Chen, Meiling ^a   Wang, Ying ^a   Gao, Baoqin ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Crotoxin; Human lung adenocarcinoma; Iressa; SPCA 1 cells

Indexed keywords

CROTALUS DURISSUS TERRIFICUS;

ANTINEOPLASTIC AGENT; CROTOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; QUINAZOLINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE;

ADENOCARCINOMA; APOPTOSIS; CARCINOGENESIS; DRUG EFFECTS; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; LUNG NEOPLASMS; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOGENESIS; CELL LINE, TUMOR; CROTOXIN; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84914161865     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2620     Document Type: Article

References (21)

1. Dempke WC, Suto T and Reck M: Targeted therapies for non-small cell lung cancer. Lung Cancer 67: 257-274, 2010.
2. Centers for Disease Control and Prevention (CDC): Lung Cancer Fact Sheet. CDC, Atlanta, GA, USA, 156-157, 2009.
3. Rübsamen K, Breithaupt H and Habermann E: Biochemistry and pharmacology of the crotoxin complex. I. Subfractionation and recombination of the crotoxin complex. Naunyn Schmiedebergs Arch Pharmakol 270: 274-288, 1971.
4. Délot E and Bon C: Model for the interaction of crotoxin, a phospholipase A2 neurotoxin, with presynaptic membranes. Biochemistry 32: 10708-10713, 1993.
5. Faure G, Harvey AL, Thomson E, Saliou B, Radvanyi F and Bon C: Comparison of crotoxin isoforms reveals that stability of the complex plays a major role in its pharmacological action. Eur J Biochem 214: 491-496, 1993.
6. Aird SD, Kaiser, II, Lewis RV and Kruggel WG: A complete amino acid sequence for the basic subunit of crotoxin. Arch Biochem Biophys 249: 296-300, 1986.
7. Corin RE, Viskatis LJ, Vidal JC and Etcheverry MA: Cytotoxicity of crotoxin on murine erythroleukemia cells in vitro. Invest New Drugs 11: 11-15, 1993.
8. Rudd CJ, Viskatis LJ, Vidal JC and Etcheverry MA: In vitro comparison of cytotoxic effects of crotoxin against three human tumors and a normal human epidermal keratinocyte cell line. Invest New Drugs 12: 183-184, 1994.
9. Newman RA, Vidal JC, Viskatis LJ, Johnson J and Etcheverry MA: VRCTC-310 - A novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity. Invest New Drugs 11: 151-159, 1993.
10. Yan CH, Yang YP, Qin ZH, Gu ZL, Reid P and Liang ZQ: Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells. Acta Pharmacol Sin 28: 540-548, 2007.
11. Zhang M, Zhang X, Bai CX, Chen J and Wei MQ: Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells. Acta Pharmacol Sin 25: 61-67, 2004.
12. Wang JH, Xie Y, Wu JC, et al: Crotoxin enhances the antitumor activity of gefinitib (Iressa) in SK-MES-1 human lung squamous carcinoma cells. Oncol Rep 27: 1341-1347, 2012.
13. Wang Q, Tan YX, Ren YB, et al: Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer 11: 271, 2011.
14. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
15. Donato NJ, Martin CA, Perez M, Newman RA, Vidal JC and Etcheverry M: Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A2 toxin. A novel growth inhibitory mechanism. Biochem Pharmacol 51: 1535-1543, 1996.
16. Condrea E: Membrane-active polypeptides from snake venom: Cardiotoxins and haemocytotoxins. Experientia 30: 121-129, 1974.
17. Yan CH, Liang ZQ, Gu ZL, Yang YP, Reid P and Qin ZH: Contributions of autophagic and apoptotic mechanisms to CrTX-induced death of K562 cells. Toxicon 47: 521-530, 2006.
18. Cura JE, Blanzaco DP, Brisson C, et al: Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer. Clin Cancer Res 8: 1033-1041, 2002.
19. Stinchcombe TE and Bogart JA: Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer. Oncologist 17: 682-693, 2012.
20. Li Y and Song L: Research progress on resistance mechanisms of epidermal growth factor receptortyrosine kinase inhibitors in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 15: 106-111, 2012 (In Chinese).
21. Brand TM, Iida M, Li C and Wheeler DL: The nuclear epidermal growth factor receptor signaling network and its role in cancer. Discov Med 12: 419-432, 2011.